戻る
Disc Medicine Inc (IRON)価格
IRON 株価推移チャート
IRON 収入
Disc Medicine Inc
$70.93
-0.15%
$-0.1
終値： Jan 16, 16:00:00 GMT-5
$70.93
0%
$0
アフターマーケット：Jan 16, 20:00:00 GMT-5
主要データ
前終値
$71.04
始値
$71.12
当日レンジ
$70.31 - $73.07
52週レンジ
$30.82 - $99.5
取引高
454.8K
平均取引高
597.7K
1株当たり利益(TTM)
-5.35
配当利回り
--
時価総額
$2.6B
IRONとは何ですか？
Disc Medicine, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of treatments for hematologic diseases. The company is headquartered in Watertown, Massachusetts and currently employs 84 full-time employees. The company went IPO on 2020-08-12. The firm's pipeline includes bitopertin for the treatment of erythropoietic porphyrias (Eps), including erythropoietic protoporphyria (EPP) and X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF), and anemia of chronic kidney disease (CKD), and DISC-3405 (formerly MWTX-003) for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, its preclinical programs also include DISC-0998, for the treatment of anemia associated with inflammatory diseases. Bitopertin is the lead product candidate in the Company's heme biosynthesis modulation portfolio. The company is developing DISC-3405, a monoclonal antibody against Transmembrane Serine Protease 6 that it licensed from Mabwell Therapeutics, Inc.